Skip to main content
Broncus Holding Corporation logo

Broncus Holding Corporation — Investor Relations & Filings

Ticker · 2216 ISIN · KYG1609T1022 HKEX Manufacturing
Open in API
Filings indexed 197 across all filing types
Latest filing 2026-05-14 Governance Information
Country HK Hong Kong
Listing HKEX 2216

About Broncus Holding Corporation

http://www.broncus.com

Broncus Holding Corporation is a medical device company focused on the research, development, manufacturing, and commercialization of innovative solutions for lung diseases. The company is recognized as a pioneer in the field of interventional pulmonology. Broncus provides comprehensive solutions across the spectrum of lung care, including advanced diagnostic solutions, lung cancer treatment solutions, and specialized solutions for chronic obstructive pulmonary disease (COPD). Its product portfolio consists of medical devices and consumables designed to improve patient outcomes in global markets, including Mainland China and the European Union.

Recent filings

Filing Released Lang Actions
ELEVENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 92% confidence The text is the full Amended and Restated Memorandum and Articles of Association for Broncus Holding Corporation, setting out the company’s constitutional governance rules, board structure, share capital provisions, member rights, meeting procedures, etc. This is not an announcement or proxy statement but the substantive governance charter itself, which falls squarely under Governance Information (CGR).
2026-05-14 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON MAY 14, 2026 AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is an announcement of the poll results from the Annual General Meeting held on May 14, 2026, detailing the votes for ordinary and special resolutions and amendments to the articles of association. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-06 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a 'Form of Proxy' for use at an Annual General Meeting (AGM) of Broncus Holding Corporation. It includes instructions for shareholders to appoint proxies to vote on their behalf at the AGM, details on voting procedures, and notes on submission deadlines. There is no financial data, management discussion, or report content. This type of document is typically classified as AGM Information, as it is a material shared for the AGM to facilitate shareholder voting and participation.
2026-04-20 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice of the Annual General Meeting (AGM) for Broncus Holding Corporation, detailing the date, location, agenda items including adoption of audited financial statements, re-election of directors, appointment of auditors, and approval of share issuance and buyback mandates. It includes procedural notes for shareholders and proxy voting. The document does not contain the actual financial statements or detailed financial data but serves as an announcement and invitation to the AGM. Therefore, it fits the category of AGM Information (AGM-R) rather than an Annual Report or other financial filings.
2026-04-20 English
(1) PROPOSALS FOR THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY AND ITS SUBSIDIARIES AND THE REPORTS OF THE DIRECTORS AND AUDITOR FOR THE YEAR ENDED DECEMBER 31, 2025; (2) RE-ELECTION O
AGM Information Classification · 100% confidence The document is a circular from Broncus Holding Corporation dated April 20, 2026, containing detailed proposals to be put forward at the Annual General Meeting (AGM) scheduled for May 14, 2026. It includes items such as approval of the audited consolidated financial statements for the year ended December 31, 2025, re-election of directors, re-appointment of auditor, general mandates to issue and buy back shares, proposed amendments to the Articles of Association, and the notice of the AGM itself. The document is comprehensive and includes biographical details of directors, explanatory statements, and the AGM notice. This type of document is typically classified as AGM Information (AGM-R) because it is the circular sent to shareholders in advance of the AGM containing all relevant information and proposals to be voted on at the meeting. It is not the Annual Report itself (10-K), nor is it a proxy solicitation or voting results announcement. The length (15,000 characters) and content confirm it is a full AGM circular. Therefore, the correct classification is AGM Information (AGM-R).
2026-04-20 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.